News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
HENSON HEIDI
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/06/2023 |
4
| HENSON HEIDI (Director) has filed a Form 4 on Perspective Therapeutics, Inc.|
Txns:
| Granted 470,000 options to buy
@ $0.55, valued at
$258.5k
Granted 230,000 options to buy
@ $0.55, valued at
$126.5k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2023 |
4
| HENSON HEIDI (Director) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 09/16/2022 |
3
| HENSON HEIDI (Director) has filed a Form 3 on LISATA THERAPEUTICS, INC. |
| 09/16/2022 |
4
| HENSON HEIDI (CFO) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Granted 125,000 options to buy
@ $2.98, valued at
$372.5k
|
|
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2021 |
3
| HENSON HEIDI (CFO) has filed a Form 3 on PARDES BIOSCIENCES, INC. |
| 01/26/2018 |
4
| HENSON HEIDI (CFO) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 81,000 options to buy
@ $20, valued at
$1.6M
|
|
| 01/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|